β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (574) π οΈ Industry Q&A (121) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ€ Insider Trades
| Date | Type | Name | A/D | Amount | Price | Security |
|---|---|---|---|---|---|---|
| 2026-12-08 | Finch Norman D. Jr. officer: SVP, GC & Corporate Secretary |
459 | 269.08 | Stock Option (Right to Buy) | ||
| 2026-08-11 | McMahon Robert W. officer: SVP & Chief Financial Officer |
7137 | 240.33 | Stock Option (Right to Buy) | ||
| 2026-03-31 | A-Award | HAUGEN JANET BRUTSCHEA director |
A | 52 | Phantom Stock Unit | |
| 2026-03-01 | A-Award | Finch Norman D. Jr. officer: SVP, GC & Corporate Secretary |
A | 1285 | Rst. Stock Unit | |
| 2026-03-01 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-03-01 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-03-01 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-03-01 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2026-03-01 | ***** | ***** |
***** | ***** | ***** | ***** |
ποΈ Explore more insider trade data for West Pharmaceutical Services!
Sign up for free or log inπ Free download! "The Checklist Value Investor β A Smarter Way to Pick Stocks"